,0
symbol,STIM
price,7.24
beta,0.0
volAvg,278912
mktCap,136561600
lastDiv,0.0
range,1.25-7.28
changes,0.56
companyName,Neuronetics Inc
currency,USD
cik,0001227636
isin,US64131A1051
cusip,64131A105
exchange,NasdaqGS
exchangeShortName,NASDAQ
industry,Diagnostics & Research
website,http://www.neuronetics.com
description,"Neuronetics, Inc. commercial stage medical technology company. The company is headquartered in Malvern, Pennsylvania and currently employs 191 full-time employees. The firm is focused on the design and development of medical devices to treat psychiatric disorders. The Companyâ€™s principal product is NeuroStar Advanced Therapy System. The company is a non-invasive treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed magnetic field to induce electrical pulses for stimulating certain areas of the brain associated with mood. The system is used to treat adult patients with major depressive disorders. The firm offers its therapy systems to psychiatrist offices in the United States."
ceo,Mr. Christopher Thatcher
sector,Healthcare
country,US
fullTimeEmployees,235
phone,18776007555
address,3222 Phoenixville Pike
city,Malvern
state,PENNSYLVANIA
zip,
dcfDiff,
dcf,9.85904
image,https://financialmodelingprep.com/image-stock/STIM.jpg
ipoDate,2018-06-28
defaultImage,True
